General Information of the Compound
Compound ID
CP0043495
Compound Name
8-(6-iodo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine
    Show/Hide
Synonyms
06IVK87M04
2fwz
6-amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-n-(1-methylethyl)-9h-purine-9-propanamine
8-((6-Iodobenzo[d][1,3]dioxol-5-yl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine
8-(6-Iodobenzo[d][1,3]dioxol-5-ylthio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine
8-[(6-Iodo-1,3-Benzodioxol-5-Yl)thio]-9-[3-(Isopropylamino)propyl]-9h-Purin-6-Amine
873436-91-0
CHEMBL200102
H71
NSC 750424
PU H71
PU-H 71
PU-H-71
PU-H71
PUH-71
UNII-06IVK87M04
    Show/Hide
Structure
Formula
C18H21IN6O2S
Molecular Weight
512.377
Canonical SMILES
CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12
    Show/Hide
InChI
InChI=1S/C18H21IN6O2S/c1-10(2)21-4-3-5-25-17-15(16(20)22-8-23-17)24-18(25)28-14-7-13-12(6-11(14)19)26-9-27-13/h6-8,10,21H,3-5,9H2,1-2H3,(H2,20,22,23)
    Show/Hide
InChIKey
SUPVGFZUWFMATN-UHFFFAOYSA-N
CAS
873436-91-0
Physicochemical Property
logP
3.2811
Rotatable Bonds
7
Heavy Atom Count
28
Polar Areas
100.11
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
9
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9549213
SID: 16613741
ChEMBL ID
CHEMBL200102
DrugBank ID
DB12638
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01478, Heat shock protein HSP 90-beta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000196 MDA-MB-468 Homo sapiens (Human)  1
1
EC50 = 10.2 nM
   TI
   LI
   LO
   TS
CL000261 SK-BR-3 Homo sapiens (Human)  2
1
EC50 = 16.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 50 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 16 nM
2 IC50 = 42 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000196 MDA-MB-468 Homo sapiens (Human)  2
1
IC50 = 58 nM
   TI
   LI
   LO
   TS
2
IC50 = 70 nM
   TI
   LI
   LO
   TS
CL000261 SK-BR-3 Homo sapiens (Human)  1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PU-H71 )
Drug Name PU-H71
Indication
Solid tumour/cancer
Phase 1
Breast cancer
Phase 1
Myelofibrosis
Phase 1
Target(s)
Heat shock protein 90 beta (HSP90B)
Inhibitor